USANA Health Sciences, Inc.USNANYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue Growth | -3.38% | +9.54% | +10.79% | +6.72% | +5.89% |
| Gross Profit Growth | -2.72% | +3.96% | +5.45% | -0.29% | +17.38% |
| EBITDA Growth | -48.01% | -15.05% | +21.82% | -52.88% | +67.47% |
| Operating Income Growth | -66.10% | -36.49% | -6.29% | -92.15% | +110.10% |
| Net Income Growth | -73.26% | -43.15% | -7.45% | -161.49% | -139.59% |
| EPS Growth | -73.86% | -43.02% | -5.45% | -164.29% | -142.17% |
| EPS Diluted Growth | -73.56% | -43.02% | -3.70% | -164.29% | -142.17% |
| Weighted Average Shares Growth | -0.35% | -0.65% | -2.94% | -4.11% | -4.00% |
| Weighted Average Shares Diluted Growth | -0.77% | -1.12% | -3.25% | -4.14% | -4.20% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -77.77% | -12.45% | +52.92% | -106.64% | -158.60% |
| Free Cash Flow Growth | -78.70% | -12.45% | +35.19% | -119.01% | -255.28% |
| Receivables Growth | +14.19% | +0.00% | +0.00% | +0.00% | +10.73% |
| Inventory Growth | +13.48% | +20.84% | +34.67% | +41.88% | +47.14% |
| Asset Growth | +18.24% | +18.64% | +16.33% | +8.24% | -0.71% |
| Book Value per Share Growth | +7.39% | +6.65% | +6.82% | +3.31% | +4.36% |
| Debt Growth | +196.89% | +1642.42% | +0.00% | +0.00% | -64.29% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +7.40% | +10.31% | +6.84% | +9.82% | -52.05% |